Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns- Famous SUVs With Low Energy Utilization In 2024
- Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- People with depression can treat themselves at home with new device
- ‘Inoculation’ helps people spot political deepfakes, study finds
- Moon rocket and weather are on NASA's side for the first astronaut launch in decades
- Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
- Creative Tech Contraptions That Will Work on Your Life
- Figure out how to Consolidate a Brain science Certificate with Social Work
